Investigators report findings from the MIRROR RCT trial, which compared pegloticase plus methotrexate vs placebo for uncontrolled gout.
The novel cocrystal of febuxostat and telmisartan was evaluated for the treatment of comorbid hyperuricemia/gout and hypertension.
Researchers used data from the ACR RISE registry to evaluate a treat-to-target approach among patients with gout receiving urate-lowering therapy.
Clinicians currently decide whether or not to prescribe urate-lowering therapies in patients with asymptomatic hyperuricemia.
Researchers assessed the incidence and potential risk factors for the development offenofibrate-associated nephrotoxicity in patients with gout.
A study of US adults demonstrated that gout is significantly more common among Black vs White individuals, with the racial disparity possibly explained by diet, social determinants of health, and chronic kidney disease.
Patients with gout flare have increased odds of cardiovascular events, independent of traditional cardiovascular risk factors.
Researchers examined the associated changes in serum urate levels with health-related quality of life in patients with gout.
In a Canadian study, more than half of older adults with CKD initiated allopurinol at a higher-than-recommended dose.
Researchers investigated the association between gout and dementia in older adult patients.